Epigenetic dysregulation in cancer

Andrew G. Muntean, Jay Hess

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

One of the great paradoxes in cellular differentiation is how cells with identical DNA sequences differentiate into so many different cell types. The mechanisms underlying this process involve epigenetic regulation mediated by alterations in DNA methylation, histone posttranslational modifications, and nucleosome remodeling. It is becoming increasingly clear that disruption of the "epigenome" as a result of alterations in epigenetic regulators is a fundamental mechanism in cancer. This has major implications for the future of both molecular diagnostics as well as cancer chemotherapy.

Original languageEnglish (US)
Pages (from-to)1353-1361
Number of pages9
JournalAmerican Journal of Pathology
Volume175
Issue number4
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Epigenomics
Histone Code
Genetic Epigenesis
Molecular Pathology
Nucleosomes
DNA Methylation
Post Translational Protein Processing
Cell Differentiation
Neoplasms
Drug Therapy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Epigenetic dysregulation in cancer. / Muntean, Andrew G.; Hess, Jay.

In: American Journal of Pathology, Vol. 175, No. 4, 2009, p. 1353-1361.

Research output: Contribution to journalArticle

Muntean, Andrew G. ; Hess, Jay. / Epigenetic dysregulation in cancer. In: American Journal of Pathology. 2009 ; Vol. 175, No. 4. pp. 1353-1361.
@article{8620684d14dd477ca8495f1d61b6b0b6,
title = "Epigenetic dysregulation in cancer",
abstract = "One of the great paradoxes in cellular differentiation is how cells with identical DNA sequences differentiate into so many different cell types. The mechanisms underlying this process involve epigenetic regulation mediated by alterations in DNA methylation, histone posttranslational modifications, and nucleosome remodeling. It is becoming increasingly clear that disruption of the {"}epigenome{"} as a result of alterations in epigenetic regulators is a fundamental mechanism in cancer. This has major implications for the future of both molecular diagnostics as well as cancer chemotherapy.",
author = "Muntean, {Andrew G.} and Jay Hess",
year = "2009",
doi = "10.2353/ajpath.2009.081142",
language = "English (US)",
volume = "175",
pages = "1353--1361",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Epigenetic dysregulation in cancer

AU - Muntean, Andrew G.

AU - Hess, Jay

PY - 2009

Y1 - 2009

N2 - One of the great paradoxes in cellular differentiation is how cells with identical DNA sequences differentiate into so many different cell types. The mechanisms underlying this process involve epigenetic regulation mediated by alterations in DNA methylation, histone posttranslational modifications, and nucleosome remodeling. It is becoming increasingly clear that disruption of the "epigenome" as a result of alterations in epigenetic regulators is a fundamental mechanism in cancer. This has major implications for the future of both molecular diagnostics as well as cancer chemotherapy.

AB - One of the great paradoxes in cellular differentiation is how cells with identical DNA sequences differentiate into so many different cell types. The mechanisms underlying this process involve epigenetic regulation mediated by alterations in DNA methylation, histone posttranslational modifications, and nucleosome remodeling. It is becoming increasingly clear that disruption of the "epigenome" as a result of alterations in epigenetic regulators is a fundamental mechanism in cancer. This has major implications for the future of both molecular diagnostics as well as cancer chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=73549098920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73549098920&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2009.081142

DO - 10.2353/ajpath.2009.081142

M3 - Article

C2 - 19717641

AN - SCOPUS:73549098920

VL - 175

SP - 1353

EP - 1361

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -